Urohealth Acquires Imagyn Medical
Unlikely to mount their own competitive assault, small companies see the big companies as valuable marketing partners and, in some cases, deep-pocketed acquirors. Big companies, for their part, see smaller players as technology incubators that supplement, in some cases even supplant their own product development efforts. But in at least one device segment, urological and gynecological devices, there's been relatively little such platform building.
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.